Axonics Price to Sales Ratio 2017-2024 | AXNX
Axonics P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2024-11-12 | 70.49 | 8.25 | |
2024-09-30 | 69.60 | $8.54 | 8.15 |
2024-06-30 | 67.23 | $8.13 | 8.27 |
2024-03-31 | 68.97 | $7.78 | 8.86 |
2023-12-31 | 62.23 | $7.44 | 8.36 |
2023-09-30 | 56.12 | $7.05 | 7.96 |
2023-06-30 | 50.47 | $6.68 | 7.56 |
2023-03-31 | 54.56 | $6.31 | 8.65 |
2022-12-31 | 62.53 | $6.09 | 10.27 |
2022-09-30 | 70.44 | $5.29 | 13.31 |
2022-06-30 | 56.67 | $4.87 | 11.63 |
2021-12-31 | 56.00 | $4.22 | 13.27 |
2021-09-30 | 65.09 | $3.93 | 16.58 |
2021-06-30 | 63.41 | $3.79 | 16.74 |
2021-03-31 | 59.89 | $3.13 | 19.11 |
2020-12-31 | 49.92 | $3.05 | 16.38 |
2020-09-30 | 51.04 | $2.45 | 20.79 |
2020-06-30 | 35.11 | $1.59 | 22.03 |
2020-03-31 | 25.41 | $1.23 | 20.66 |
2019-12-31 | 27.71 | $0.49 | 56.94 |
2019-09-30 | 26.92 | $0.21 | 128.72 |
2019-06-30 | 40.97 | $1.24 | 33.17 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.603B | $0.366B |
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $10.500B | 0.00 |
Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
Privia Health (PRVA) | United States | $2.710B | 225.80 |
Enovis (ENOV) | United States | $2.621B | 17.77 |
Omnicell (OMCL) | United States | $2.264B | 74.08 |
Azenta (AZTA) | United States | $2.250B | 112.17 |
10x Genomics (TXG) | United States | $1.898B | 0.00 |
Schrodinger (SDGR) | United States | $1.620B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
Phreesia (PHR) | United States | $1.235B | 0.00 |
Standard BioTools (LAB) | United States | $0.763B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
Talkspace (TALK) | United States | $0.569B | 0.00 |
Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
Pulmonx (LUNG) | United States | $0.278B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
TruBridge (TBRG) | United States | $0.234B | 67.96 |
P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
American Well (AMWL) | United States | $0.136B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.063B | 0.00 |
111 (YI) | China | $0.056B | 0.00 |
CareCloud (CCLD) | United States | $0.051B | 0.00 |
Zepp Health (ZEPP) | China | $0.049B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |